Canine Brucellosis Antibody Test Kit D-Tec Cb

Lab Reagents

Canine Brucellosis Test Laboratories manufactures the canine brucellosis antibody test kit d-tec cb reagents distributed by Genprice. The Canine Brucellosis Antibody Test Kit D-Tec Cb reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact canine brucellosis test. Other Canine products are available in stock. Specificity: Canine Category: Brucellosis Group: Antibody Test

Antibody Test information

Tec Antibody
F54447-0.4ML 0.4 ml
EUR 379

Tyrosine-Protein Kinase Tec (TEC) Antibody
20-abx135699
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Tec Protein Tyrosine Kinase (TEC) Antibody
20-abx131503
  • EUR 526.80
  • EUR 159.60
  • EUR 1479.60
  • EUR 710.40
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Tec Protein Tyrosine Kinase (TEC) Antibody
20-abx131504
  • EUR 510.00
  • EUR 159.60
  • EUR 1446.00
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Tyrosine-Protein Kinase Tec (TEC) Antibody
abx011600-100ul 100 ul
EUR 493.2

Tyrosine-Protein Kinase Tec (TEC) Antibody
abx033645-400ul 400 ul
EUR 627.6

Tyrosine-Protein Kinase Tec (TEC) Antibody
abx033645-80l 80 µl
EUR 343.2

Canine Parvovirus Antibodies Rapid Test Kit (Colloidal gold)
abx092032-40tests 40 tests
EUR 427.2

D-Nase Test Agar 500gm
211179 EACH
EUR 265.62

Canine Cath-D ELISA Kit
ECC0703 96Tests
EUR 625.2

Canine D-La ELISA Kit
ECD0249 96Tests
EUR 625.2

Canine D-LDH ELISA Kit
ECD0250 96Tests
EUR 625.2

Canine VEGF-D ELISA Kit
ECV0019 96Tests
EUR 625.2

CB-TH
5-00940 4 x 1mg Ask for price

CB 300919
A3285-10 10 mg
EUR 1036.8
Description: CB 300919 is a potential therapy for ovarian cancer. Preclinical data showed that this quinazoline-based compound CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft.

CB 300919
A3285-5 5 mg
EUR 606
Description: CB 300919 is a potential therapy for ovarian cancer. Preclinical data showed that this quinazoline-based compound CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft.

CB 300919
A3285-50 50 mg
EUR 3316.8
Description: CB 300919 is a potential therapy for ovarian cancer. Preclinical data showed that this quinazoline-based compound CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft.